Wuhan Hiteck Biological PharmaLtd Balance Sheet Health
Financial Health criteria checks 4/6
Wuhan Hiteck Biological PharmaLtd has a total shareholder equity of CN¥2.5B and total debt of CN¥45.4M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are CN¥2.9B and CN¥490.1M respectively.
Key information
1.8%
Debt to equity ratio
CN¥45.37m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥877.57m |
| Equity | CN¥2.45b |
| Total liabilities | CN¥490.13m |
| Total assets | CN¥2.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300683's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥327.6M).
Long Term Liabilities: 300683's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥162.5M).
Debt to Equity History and Analysis
Debt Level: 300683 has more cash than its total debt.
Reducing Debt: 300683's debt to equity ratio has increased from 0% to 1.8% over the past 5 years.
Debt Coverage: 300683's debt is well covered by operating cash flow (169.4%).
Interest Coverage: Insufficient data to determine if 300683's interest payments on its debt are well covered by EBIT.